Navigation Links
Regeneron Reports Third Quarter 2009 Financial and Operating Results
Date:11/3/2009

on's agreements with the sanofi-aventis Group and Bayer HealthCare, to be canceled or to terminate without any product success, risks associated with third party intellectual property, and other material risks. A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-K for the year ended December 31, 2008 and Form 10-Q for the quarter ended September 30, 2009. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise unless required by law.

    Contacts Information:
    Peter Dworkin                             Laura Lindsay
    Investor Relations                        Media Relations
    914.345.7640                              914.345.7800
    peter.dworkin@regeneron.com               laura.lindsay@regeneron.com
                  REGENERON PHARMACEUTICALS, INC.
                CONDENSED BALANCE SHEETS (Unaudited)
                           (In thousands)


                                          September 30, December 31,
                                              2009          2008
                                          ------------  ------------
                                                         (Revised)*

    ASSETS
    Cash, restricted cash, and marketable
     securities                             $438,596      $527,461
    Receivables                               67,766        35,212
    Property, plant, and equipment, net      215,169       142,035
    Other assets                              20,661        19,512
                                              ------        ------

  
'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Spherix Reports Second Quarter Earnings
7. Tapestry Reports Second Quarter 2007 Results
8. Callisto Reports on Second-Quarter 2007 Milestones
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...
(Date:5/17/2013)... -- United Medical Education, a company that provides online ... Life Support (PALS) and Basic Life Support (BLS), is ... course manuals. In order to gain access to ... account with the company. By offering the free learning ... is setting a precedent among similar companies. ...
(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The escalation of new ... placing renewed emphasis on alternate delivery technologies. Alternate ... number of factors are converging to create both ... their delivery device partners . These include new ... growing trend toward self-administration for chronic diseases, shifting ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... and LOS ANGELES, Oct. 14 /PRNewswire-Asia/ -- China,Yongxin Pharmaceuticals, ... Company"), a leading manufacturer, distributor and,retailer of pharmaceuticals in ... second quarter of 2009 which ended June 30,2009. , ... of 2009 were essentially flat at,approximately $14.6 million compared ...
... VSCP ), a leading provider of quantitative imaging for ... chief business and financial officer, will be presenting a corporate ... Forum in San Francisco, California. Ms. Henderson is scheduled to ... 2009 at the Palace Hotel, San Francisco. , A live ...
Cached Medicine Technology:China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 2China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 3China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 4China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 5China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 6China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 7China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 8China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 9China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 10China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 11VirtualScopics to Present at the 8th Annual Bio Investor Forum 2
(Date:5/19/2013)... (PRWEB) May 20, 2013 Due to ... with online advertising, MileageAds.com has decided to invite bloggers ... through their ad network. , Businesses in the ... success with online marketing, specifically with ad networks. ... information and legal services and are unsure where to ...
(Date:5/19/2013)... physicians are key decisionmakers for nearly half of all ... in reducing health care costs, according to a new ... admissions from the ER increased by 17 percent over ... hospital admissions between 2003 and 2009. Hospital inpatient ... accounting for 31 percent of the nation,s health care ...
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... tickets for his two concerts in Vegas in October ... 20th. Additionaly, during the spring and summer months of ... the country. , Whenever people hear “It’s Five ... and hear the voice of Jimmy Buffett inside their heads. ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Daily Gossip reporters ... 17 Cheat Foods That Burn Fat to a ... readers. , The review is a detailed ... by the writer's recommendation. , The two nutritionists have discovered ... is responsible for the caloric intake and expenditure of our ...
(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...
Breaking Medicine News(10 mins):Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2Health News:ER docs are key to reducing health care costs 2Health News:ER docs are key to reducing health care costs 3Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3
... Multimedia Effort to Launch Contact Lenses in Puerto ... ... 28 Johnson & Johnson Vision,Care, today announced a multi-faceted marketing campaign ... Contact Lenses in Puerto Rico, the Caribbean and Central,America., Following its ...
... in Heavy Rotation Through Primary, OAKLAND, Calif., ... crucial,primary vote Tuesday, the National Nurses Organizing Committee/California,Nurses ... Ohio with,an emphatic message to the presidential candidates ... healthcare reform., The 60-second radio ad is ...
... lupus erythematosus (SLE), commonly known as lupus, can affect ... skin, kidneys, heart, nervous system, and brain. Along ... and skin rashes, neurologic and psychiatric events often accompany ... 37 and 95 percent of SLE patients experience signs ...
... Kimmel Cancer Center in Philadelphia have shown that they ... laboratory and in experimental animal models by blocking a ... The work proves that the protein, Stat5, is both ... is a viable target for drug therapy. , The ...
... Year 2007 Highlights, - Revenue for the fourth quarter was $469.5 ... year was $1.8 billion, a 40% ... - Average occupancy for the fourth quarter was 90.6% and for the full ... from 90.4% for the full year of 2006., - Same store Facility ...
... 27 Actavis Group, the,international generic pharmaceuticals company, ... U.S. Food & Drug Administration., The four ... generic equivalent of,Bontril(R) tablets by Valeant Pharmaceuticals, are ... sales of Phendimetrazine tartrate tablets,had annual sales of ...
Cached Medicine News:Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 2Health News:Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers 3Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 2Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 3Health News:Autoantibodies and neuropsychiatric events in lupus 2Health News:Autoantibodies and neuropsychiatric events in lupus 3Health News:Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 3Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 4Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 5Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 6Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 7Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 8Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 9Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 10Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 11Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 12Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 13Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 14Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 15Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 16Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 17Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 18Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 19Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 20Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 21Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 22Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 23Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 24Health News:Actavis Extends Portfolio With Four New Products in the U.S. 2
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator. , ,Most Appropriate for the Proximal Femur, Metatarsal/Tar...
... Pulsed ElectroMagnetic Field (PEMF) bone growth stimulation ... option for long bone and small bone ... cast, orthopedic brace, or clothing without lessening ... in one compact, lightweight unit including success ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Cannulated Interference Screws. Optimal ... and graft selection options. ... without deformation, and chamfered ... threaded atraumatic tissue fixation. ...
Medicine Products: